News: Neurotech Announces the Opening of It’s GMP Manufacturing Facility in Cumberland, Rhode Island read more

News: Neurotech Granted Fast Track Designations from the FDA for NT-501 in Two Indications?Retinitis Pigmentosa and Dry Age-Related Macular Degeneration read more

News: Neurotech Pharmaceuticals Announces Rhode Island Expansion Plan read more

News: Neurotech Announces Completion of Enrollment of its Phase II/III Retinitis Pigmentosa and Phase II Dry Age Related Macular Degeneration Clinical Studies read more

For information about our clinical studies involving retinitis pigmentosa or dry AMD please visit the following sites:

http://www.clinicaltrials.gov/

http://www.centerwatch.com/

http://www.RenoirRetinalStudies.com/